Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 15172-15173 [E7-5918]
Download as PDF
<![CDATA[
15172
Federal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Notices
Register and served on the parties to the
hearing.
NUCLEAR REGULATORY
COMMISSION
III. Opportunity To Provide Written
Comments
[Docket Nos. 50–361 and 50–362]
In accordance with 10 CFR 2.1305, as
an alternative to requests for hearing
and petitions to intervene, comments
with respect to this action should be
provided in writing by April 30, 2007.
The Commission will consider and, if
appropriate, respond to these
comments, but such comments will not
otherwise constitute part of the
decisional record. Comments should be
submitted to the Secretary, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001, Attention: Rulemakings
and Adjudications Staff, and should cite
the publication date and page number of
this Federal Register notice.
IV. Further Information
For further details with respect to this
action, see the application dated January
19, 2007, and supplements dated;
February 23, 2007, and March 2, 2007,
available for public inspection at the
Commission’s Public Document Room
(PDR), located at One White Flint North,
Public File Area O1 F21, 11555
Rockville Pike (first floor), Rockville,
Maryland. Publicly available records
will be accessible electronically from
the Agencywide Documents Access and
Management System’s (ADAMS) Public
Electronic Reading Room on the Internet
at the NRC Web site, https://
www.nrc.gov/reading-rm/adams.html.
Persons who do not have access to
ADAMS, or who encounter problems in
accessing the documents located in
ADAMS should contact the NRC PDR
Reference staff by telephone at 1–800–
397–4209, or 301–415–4737, or via email to pdr@nrc.gov.
Dated at Rockville, Maryland this 23rd day
of March 2007.
For the Nuclear Regulatory Commission.
Gary S. Janosko,
Deputy Director, Fuel Facility Licensing
Directorate, Division of Fuel Cycle Safety and
Safeguards, Office of Nuclear Material Safety
and Safeguards.
[FR Doc. E7–5937 Filed 3–29–07; 8:45 am]
cprice-sewell on PROD1PC66 with NOTICES
BILLING CODE 7590–01–P
Southern California Edison Company,
San Diego Gas and Electric Company,
the City of Riverside, CA, Notice of
Withdrawal of Application for
Amendment to Facility Operating
License
The U.S. Nuclear Regulatory
Commission (the Commission) has
granted the request of Southern
California Edison (the licensee) to
withdraw its February 28, 2006,
application for proposed amendment to
Facility Operating License Nos. NPF–10
and NPF–15 for the San Onofre Nuclear
Generating Station, Units 2 and 3,
located in San Diego County, California.
The proposed amendment would
have revised Technical Specifications
(TSs) 3.8.1, ‘‘AC [alternating current]
Sources—Operating,’’ 3.8.4, ‘‘DC [direct
current] Sources—Operating,’’ 3.8.5,
‘‘DC Sources—Shutdown,’’ 3.8.6,
‘‘Battery Cell Parameters,’’ 3.8.7,
‘‘Inverters—Operating,’’ and 3.8.9,
‘‘Distribution Systems—Operating.’’
This change would have also added a
new Battery Monitoring and
Maintenance Program, Section 5.5.2.16.
The Commission had previously
issued a Notice of Consideration of
Issuance of Amendment published in
the Federal Register on July 5, 2006 (71
FR 38185). However, by letter dated
March 15, 2007, the licensee withdrew
the proposed change.
For further details with respect to this
action, see the application for
amendment dated February 28, 2006,
and the licensee’s letter dated March 15,
2007, which withdrew the application
for license amendment. Documents may
be examined, and/or copied for a fee, at
the NRC’s Public Document Room
(PDR), located at One White Flint North,
Public File Area O1 F21, 11555
Rockville Pike (first floor), Rockville,
Maryland. Publicly available records
will be accessible electronically from
the Agencywide Documents Access and
Management Systems (ADAMS) Public
Electronic Reading Room on the Internet
at the NRC Web site, https://
www.nrc.gov/reading-rm.html. Persons
who do not have access to ADAMS or
who encounter problems in accessing
the documents located in ADAMS
should contact the NRC PDR Reference
staff by telephone at 1–800–397–4209,
or 301–415–4737 or by e-mail to
pdr@nrc.gov.
Dated at Rockville, Maryland, this 23rd day
of March 2007.
VerDate Aug<31>2005
15:49 Mar 29, 2007
Jkt 211001
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
For the Nuclear Regulatory Commission.
Nageswaran Kalyanam,
Project Manager, Plant Licensing Branch IV,
Division of Operating Reactor Licensing,
Office of Nuclear Reactor Regulation.
[FR Doc. E7–5936 Filed 3–29–07; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Call for Nominations
U.S. Nuclear Regulatory
Commission.
ACTION: Call for Nominations.
AGENCY:
SUMMARY: The U.S. Nuclear Regulatory
Commission (NRC) is advertising for
nominations for the position of nuclear
pharmacist on the Advisory Committee
on the Medical Uses of Isotopes
(ACMUI).
Nominations are due on or
before May 29, 2007.
Nomination Process: Submit an
electronic copy of resume or curriculum
vitae to Ms. Ashley M. Tull,
amt1@nrc.gov. Please ensure that
resume or curriculum vitae includes the
following information, if applicable:
education, certification; professional
association membership and committee
membership activities; duties and
responsibilities in current and previous
clinical, research, and/or academic
position(s), including traditional
nuclear medicine, preparing and
dispensing radiopharmaceuticals, and
shipping and receiving radioactive
material.
DATES:
FOR FURTHER INFORMATION CONTACT:
Ashley M. Tull, U.S. Nuclear Regulatory
Commission, Office of Federal and State
Materials and Environmental
Management Programs, Mail Stop T8–
F3, Washington, DC 20555; (301) 415–
5294; amt1@nrc.gov.
SUPPLEMENTARY INFORMATION: The
ACMUI advises NRC on policy and
technical issues that arise in the
regulation of the medical use of
byproduct material. Responsibilities
include providing comments on changes
to NRC rules, regulations, and guidance
documents; evaluating certain nonroutine uses of byproduct material;
providing technical assistance in
licensing, inspection, and enforcement
cases; and bringing key issues to the
attention of NRC for appropriate action.
ACMUI members possess the medical
and technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) Nuclear
E:\FR\FM\30MRN1.SGM
30MRN1
Federal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Notices
medicine physician; (b) nuclear
cardiologist; (c) medical physicist in
nuclear medicine unsealed byproduct
material; (d) therapy medical physicist;
(e) radiation safety officer; (f) nuclear
pharmacist; (g) two radiation
oncologists; (h) patients’ rights
advocate; (i) Food and Drug
Administration representative; (j) State
representative; and (k) health care
administrator.
NRC is inviting nominations for the
nuclear pharmacist appointment to the
ACMUI. The term of the individual
currently occupying this position will
end September 2008. Committee
members currently serve a four-year
term and may be considered for
reappointment to an additional term.
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to Committee business.
Members who are not Federal
employees are compensated for their
service. In addition, non-Federal
members are reimbursed travel,
secretarial and correspondence
expenses. Full-time Federal employees
are reimbursed travel expenses only.
Security Background Check: The
selected nominee will undergo a
thorough security background check.
Security paperwork may take the
nominee several weeks to complete.
Nominees will also be required to
complete a financial disclosure
statement to avoid conflicts of interest.
Dated at Rockville, Maryland this 26th day
of March 2007.
For the U.S. Nuclear Regulatory
Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E7–5918 Filed 3–29–07; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
cprice-sewell on PROD1PC66 with NOTICES
Advisory Committee on Nuclear Waste
Meeting on Planning and Procedures;
Notice of Meeting
The Advisory Committee on Nuclear
Waste (ACNW) will hold a Planning and
Procedures meeting on April 10, 2007,
Room T–2B1, 11545 Rockville Pike,
Rockville, Maryland. The entire meeting
will be open to public attendance, with
the exception of a portion that may be
closed pursuant to 5 U.S.C. 552b(c)(2)
and (6) to discuss organizational and
personnel matters that relate solely to
internal personnel rules and practices of
ACNW, and information the release of
which would constitute a clearly
unwarranted invasion of personal
privacy.
VerDate Aug<31>2005
15:49 Mar 29, 2007
Jkt 211001
The agenda for the subject meeting
shall be as follows:
Tuesday, April 10, 2007—8:30 a.m.–10
a.m.
The Committee will discuss proposed
ACNW activities and related matters.
The purpose of this meeting is to gather
information, analyze relevant issues and
facts, and formulate proposed positions
and actions, as appropriate, for
deliberation by the full Committee.
Members of the public desiring to
provide oral statements and/or written
comments should notify the Designated
Federal Official, Mr. Antonio F. Dias
(Telephone: 301/415–6805) between
8:15 a.m. and 5 p.m. (ET) five days prior
to the meeting, if possible, so that
appropriate arrangements can be made.
Electronic recordings will be permitted
only during those portions of the
meeting that are open to the public.
Further information regarding this
meeting can be obtained by contacting
the Designated Federal Official between
8:15 a.m. and 5 p.m. (ET). Persons
planning to attend this meeting are
urged to contact the above named
individual at least two working days
prior to the meeting to be advised of any
potential changes in the agenda.
Dated: March 22, 2007.
Antonio F. Dias,
Acting Branch Chief, ACNW.
[FR Doc. E7–5919 Filed 3–29–07; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Interim Regulatory Guide: Issuance,
Availability
The U.S. Nuclear Regulatory
Commission (NRC) has issued an
interim revision to an existing guide in
the agency’s Regulatory Guide Series.
This series has been developed to
describe and make available to the
public such information as methods that
are acceptable to the NRC staff for
implementing specific parts of the
agency’s regulations, techniques that the
staff uses in evaluating specific
problems or postulated accidents, and
data that the staff needs in its review of
applications for permits and licenses.
The revised guide, entitled ‘‘Quality
Assurance for Radiological Monitoring
Programs (Inception Through Normal
Operations to License Termination)—
Effluent Streams and the Environment,’’
is identified as Interim Revision 2 of
Regulatory Guide 4.15. Like its
predecessor, this interim revision
describes a method that the NRC staff
considers acceptable for use in
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
15173
designing and implementing programs
to ensure the quality of the results of
measurements of radioactive materials
in the effluents from, and environment
outside of, facilities that process, use, or
store radioactive materials during all
phases of the facility’s life cycle. Quality
assurance (QA) is a fundamental
expectation of Title 10, ‘‘Energy,’’ of the
Code of Federal Regulations (10 CFR)
for items and activities that are relied on
to protect the health and safety of the
public and the environment.
This interim guide serves as a final
regulatory guide for, and may be used
by applicants and licensees of nuclear
power reactors. It also presents draft
NRC staff positions on a method for
designing and implementing QA
programs for use by non-nuclear power
reactor applicants and licensees subject
to the agency’s QA requirements. The
NRC staff seeks public comments on
this regulatory guide with respect to its
application to such licensees. The NRC
staff will issue this guide in final form
after resolving any comments received
during the public comment period.
Interim Revision 2 of Regulatory
Guide 4.15 specifically applies to
facilities for which NRC regulations
require routine monitoring of
radioactive effluents to the
environment, and particularly those
facilities licensed under the following
regulations:
• 10 CFR Part 50, ‘‘Domestic
Licensing of Production and Utilization
Facilities’’
• 10 CFR Part 52, ‘‘Licenses,
Certifications, and Approvals for
Nuclear Power Plants’’
• 10 CFR Part 61, ‘‘Licensing
Requirements for Land Disposal of
Radioactive Waste’’
• 10 CFR Part 72, ‘‘Licensing
Requirements for the Independent
Storage of Spent Nuclear Fuel, HighLevel Radioactive Waste, and ReactorRelated Greater Than Class C Waste’’
• 10 CFR Part 76, ‘‘Certification of
Gaseous Diffusion Plants’’
The guidance may also apply to other
NRC-licensed facilities, for which the
agency may impose specific license
conditions for effluent or environmental
monitoring, as deemed necessary to
ensure the health and safety of the
public and the environment, including
those licensed under the following
regulations:
• 10 CFR Part 30, ‘‘Rules of General
Applicability to Domestic Licensing of
Byproduct Material’’
• 10 CFR Part 40, ‘‘Domestic
Licensing of Source Material’’
• 10 CFR Part 70, ‘‘Domestic
Licensing of Special Nuclear Material’’
E:\FR\FM\30MRN1.SGM
30MRN1
]]>Agencies
[Federal Register Volume 72, Number 61 (Friday, March 30, 2007)]
[Notices]
[Pages 15172-15173]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-5918]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Call for
Nominations
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Call for Nominations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising
for nominations for the position of nuclear pharmacist on the Advisory
Committee on the Medical Uses of Isotopes (ACMUI).
DATES: Nominations are due on or before May 29, 2007.
Nomination Process: Submit an electronic copy of resume or
curriculum vitae to Ms. Ashley M. Tull, amt1@nrc.gov. Please ensure
that resume or curriculum vitae includes the following information, if
applicable: education, certification; professional association
membership and committee membership activities; duties and
responsibilities in current and previous clinical, research, and/or
academic position(s), including traditional nuclear medicine, preparing
and dispensing radiopharmaceuticals, and shipping and receiving
radioactive material.
FOR FURTHER INFORMATION CONTACT: Ashley M. Tull, U.S. Nuclear
Regulatory Commission, Office of Federal and State Materials and
Environmental Management Programs, Mail Stop T8-F3, Washington, DC
20555; (301) 415-5294; amt1@nrc.gov.
SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and
technical issues that arise in the regulation of the medical use of
byproduct material. Responsibilities include providing comments on
changes to NRC rules, regulations, and guidance documents; evaluating
certain non-routine uses of byproduct material; providing technical
assistance in licensing, inspection, and enforcement cases; and
bringing key issues to the attention of NRC for appropriate action.
ACMUI members possess the medical and technical skills needed to
address evolving issues. The current membership is comprised of the
following professionals: (a) Nuclear
[[Page 15173]]
medicine physician; (b) nuclear cardiologist; (c) medical physicist in
nuclear medicine unsealed byproduct material; (d) therapy medical
physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g)
two radiation oncologists; (h) patients' rights advocate; (i) Food and
Drug Administration representative; (j) State representative; and (k)
health care administrator.
NRC is inviting nominations for the nuclear pharmacist appointment
to the ACMUI. The term of the individual currently occupying this
position will end September 2008. Committee members currently serve a
four-year term and may be considered for reappointment to an additional
term.
Nominees must be U.S. citizens and be able to devote approximately
160 hours per year to Committee business. Members who are not Federal
employees are compensated for their service. In addition, non-Federal
members are reimbursed travel, secretarial and correspondence expenses.
Full-time Federal employees are reimbursed travel expenses only.
Security Background Check: The selected nominee will undergo a
thorough security background check. Security paperwork may take the
nominee several weeks to complete. Nominees will also be required to
complete a financial disclosure statement to avoid conflicts of
interest.
Dated at Rockville, Maryland this 26th day of March 2007.
For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E7-5918 Filed 3-29-07; 8:45 am]
BILLING CODE 7590-01-P
